Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?

Published:2014-05 Issue: Volume:62 Page:56-63
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Mutsaers Anthony J.,Walkley Carl R.

Funder

National Health and Medical Research Council of Australia

Australian Sarcoma Study Group

Victorian Cancer Council

OVC Pet Trust

AACR-Aflac Inc, Career Development Award for Pediatric Cancer Research

Victorian State Government Operational Infrastructure Support Program

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference81 articles.

1. The elusive nature and function of mesenchymal stem cells;Nombela-Arrieta;Nat Rev Mol Cell Biol,2011

2. Incidence and survival of malignant bone sarcomas in England 1979–2007;Whelan;Int J Cancer,2012

3. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: national cancer data base report;Damron;Clin Orthop Relat Res,2007

4. Cells of origin in cancer;Visvader;Nature,2011

5. Mesenchymal stem cell transformation and sarcoma genesis;Xiao;Clin Sarcoma Res,2013

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic variation near GRB10 associated with bone growth and osteosarcoma risk in canine and human populations;Cancer Epidemiology;2024-10

2. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas;Scientific Reports;2024-08-20

3. Predicting the Efficacy of Novel Synthetic Compounds in the Treatment of Osteosarcoma via Anti-Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets;Medicinal Chemistry;2024-08

4. A Novel Highly Invasive Cell-Related Gene Signature for Predicting the Prognosis and Treatment of Osteosarcoma;2024-06-26

5. Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas;2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3